The Relationship between D’Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers
Current Oncology · 2024
DOI: 10.3390/curroncol31090391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Ozge Ulas Babacan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, School of Medicine, Tokat Gaziosmanpasa University, 60250 Tokat, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Gallium Radioisotopes, Gallium Isotopes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Onko Koçsel İlaç San. ve Tic. A.Ş..
Abstract (Originalsprache)
Introduction
This study aimed to evaluate the relationship between pathological and clinical risk classifications in newly diagnosed prostate cancer patients, and 68Ga-PSMA PET/CT data and serum Prostate Specific Antigen (PSA) values.
Method
A total of 203 patients who were diagnosed with prostate cancer between 2019 and 2023, who had not yet received treatment and who underwent 68Ga-PSMA PET/CT for staging purposes were included in this study.
Results
There was a substantial correlation between D’Amico risk classification, Gleason score, ISUP classification, and the presence or absence of metastasis (p < 0.0001). The median SUVmax value of the prostate gland and the D’Amico risk classification were statistically significantly correlated. (p < 0.0001). There was a statistically significant correlation between the ISUP classification and the PSA value and prostate gland SUVmax value (p < 0.0001). There was a significant correlation between the median SUVmax values of the prostate gland at the time of diagnosis and the patients with and without metastases (p < 0.0001). According to the data obtained from ROC analysis, patients with prostate gland SUVmax values of 8.75 and above were found to have a high probability of metastasis with a sensitivity of 78.9% and a specificity of 59.05%.
Conclusion
Our study showed that 68Ga-PSMA PET/CT is a highly effective method for staging newly diagnosed high-risk prostate cancer. The probability of metastasis was found to be dramatically increased in Gleason 8 and above. According to D’Amico risk classification, metastasis was detected in at least half of high-risk patients. Since the sensitivity of metastasis was 78.9% in patients with prostate gland SUVmax value above 8.75, we think that these patients should be carefully reported in terms of metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, School of Medicine, Tokat Gaziosmanpasa University, 60250 Tokat, Turkey.
- Department of Nuclear Medicine, School of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey.
ORCID-Profile: Kerim Seker
Förderung
- Onko Koçsel İlaç San. ve Tic. A.Ş.
Zitieren
APA
Ulas Babacan, O., Hasbek, Z., & Seker, K. (2024). The Relationship between D’Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers. Current Oncology. https://doi.org/10.3390/curroncol31090391
Vancouver
Ulas Babacan O, Hasbek Z, Seker K. The Relationship between D’Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers. Current Oncology. 2024. doi:10.3390/curroncol31090391
BibTeX
@article{UlasBabacan2024,
author = {Ulas Babacan, Ozge and Hasbek, Zekiye and Seker, Kerim},
title = {The Relationship between D’Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers},
journal = {Current Oncology},
year = {2024},
doi = {10.3390/curroncol31090391}
}
EUVIMED